Peter H. Diamandis, MD
@PeterDiamandis · Dec 28, 2022
• A combination of Moderna’s experimental cancer vaccine, referred as mRNA-4157/V940, and Merck’s immunotherapy called Keytruda is successful against melanoma, considered the deadliest skin cancer, reducing the risk of recurrence or death by 44% during Phase 2 clinical trials.
Elon Musk
@elonmusk
Synthetic mRNA has incredible potential!
05:25 PM · December 28, 2022 · 549.9K views
867
248
3.6K